Trulieve Cannabis (TCNNF) Cash & Equivalents (2020 - 2025)
Trulieve Cannabis has reported Cash & Equivalents over the past 6 years, most recently at $255.5 million for Q4 2025.
- Quarterly results put Cash & Equivalents at $255.5 million for Q4 2025, up 7.01% from a year ago — trailing twelve months through Dec 2025 was $255.5 million (up 7.01% YoY), and the annual figure for FY2025 was $255.5 million, up 7.01%.
- Cash & Equivalents for Q4 2025 was $255.5 million at Trulieve Cannabis, down from $449.2 million in the prior quarter.
- Over the last five years, Cash & Equivalents for TCNNF hit a ceiling of $449.2 million in Q3 2025 and a floor of $823000.0 in Q1 2022.
- Median Cash & Equivalents over the past 5 years was $220.1 million (2021), compared with a mean of $226.2 million.
- Biggest five-year swings in Cash & Equivalents: tumbled 99.49% in 2022 and later surged 22456.74% in 2023.
- Trulieve Cannabis' Cash & Equivalents stood at $226.6 million in 2021, then decreased by 8.58% to $207.2 million in 2022, then dropped by 2.81% to $201.4 million in 2023, then increased by 18.59% to $238.8 million in 2024, then grew by 7.01% to $255.5 million in 2025.
- The last three reported values for Cash & Equivalents were $255.5 million (Q4 2025), $449.2 million (Q3 2025), and $392.6 million (Q2 2025) per Business Quant data.